Prostate Cancer - Results from #28540

Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer - Abstract February 25, 2011

Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: Improved outcomes with stringent enrollment criteria - Abstract February 25, 2011

Depression related to (neo)adjuvant hormonal therapy for prostate cancer - Abstract February 25, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Management of castration-resistant prostate cancer after initial chemotherapy - Session Highlights February 25, 2011

The pattern of prostate cancer local recurrence after radiation and salvage cryoablation - Abstract February 24, 2011

One-step customized transurethral resection of the prostate and permanent implant brachytherapy for selected prostate cancer patients: Technically feasible but too toxic - Abstract February 24, 2011

Expression of leukemia/lymphoma related factor (LRF/Pokemon) in human benign prostate hyperplasia and prostate cancer - Abstract February 24, 2011

Novel approaches and future directions in castration-resistant prostate cancer - Abstract February 24, 2011

Prostate cancer does not influence androgen levels: A radical prostatectomy cohort study - Abstract February 24, 2011

Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy - Abstract February 24, 2011

Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [111In]-labeled affibody molecule ZEGFR:2377 and cetuximab - Abstract February 24, 2011

Nutritional aspects of primary prostate cancer prevention - Abstract February 24, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Initial report of RTOG 9601, a phase III trial in prostate cancer - Session Highlights February 24, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Effect of dutasteride on prostate cancer progression and cancer diagnosis on rebiopsy in the REDEEM active surveillance study - Session Highlights February 24, 2011

Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer - Abstract February 23, 2011

Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer - Abstract February 23, 2011

Oncolytic virus-initiated protective immunity against prostate cancer - Abstract February 23, 2011

Testicular metastases from prostate cancer - Abstract February 23, 2011

Cost-effectiveness of prostate specific antigen screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer - Abstract February 22, 2011

Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer - Abstract February 22, 2011

Page 1428 of 1436